Peer-reviewedCC BY-NC-NDTranslational cancer research
The m6A/METTL3 modifies USP11 to promote Warburg effect progression of colon cancer undifferentiated by HIF-1α/YAP signaling pathway
4 affiliations
- 1The Nuclear Medicine Department of the First Affiliated Hospital of Wannan Medical University, Wuhu, ;
- 2The Ultrasound Medicine Department of the First Affiliated Hospital of Wannan Medical University, Wuhu, ;
- 3Medical Imaging Center of the First Affiliated Hospital of Wannan Medical University , Wuhu, ;
- 4Department of Drug Clinical Evaluation , Yijishan Hospital of Wannan Medical University , Wuhu, ;
Related
- LncRNA MALAT1 Targets METTL3 to Orchestrate INPP5B/LRIG2 Signaling and Promote Non‐Small Cell Lung Cancer Progression
- Frequency and predictors of disease progression in contemporary ACPA-negative undifferentiated arthritis in a treated-to-target early arthritis clinic
- CST1 stabilizes GPX4 to suppress ferroptosis and promote bladder cancer progression
- A CD109-SMURF2 Axis Diverts EGFR from Degradation to Sustain Oncogenic Signaling and Promote Squamous Cell Carcinoma Invasion and Stemness
- Does acute inflammation triggered by infection promote cancer progression?
BibTeX
@article{wang2026m6amettl3,
title = {{The m6A/METTL3 modifies USP11 to promote Warburg effect progression of colon cancer undifferentiated by HIF-1α/YAP signaling pathway}},
author = {Yingying Wang and Feifei Zhu and Xiaolei Chen and Lei Feng and Zhichen Pu},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657828},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - The m6A/METTL3 modifies USP11 to promote Warburg effect progression of colon cancer undifferentiated by HIF-1α/YAP signaling pathway
AU - Yingying Wang
AU - Feifei Zhu
AU - Xiaolei Chen
AU - Lei Feng
AU - Zhichen Pu
PY - 2026
DA - 2026/08/18
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657828
SN - 2218-676X
ER -